Rezolute (RZLT) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T18:28:13.971Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:28:13.971Z.

Quote observation: 2026-10-06T18:25:11.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 4.2496
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.76

FMP input reference: eb6c183c54b52a3f5be7b88cd35f52a8db6123751fb387d2cb2c86d403628cdc

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

RZLT PE Ratio Metrics

PE RATIO

N/A

RZLT Competitors' PE Ratio

RZLT

Rezolute, Inc.

Current

Market Cap

$409.20M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MYGN

Myriad Genetics, Inc.

vs RZLT

Market Cap

$410.18M

PE Ratio

N/A

TTM Avg

178.15

3Y Avg

100.22

5Y Avg

67.93

NGNE

Neurogene Inc.

vs RZLT

Market Cap

$408.17M

PE Ratio

N/A

TTM Avg

21.17

3Y Avg

21.07

5Y Avg

21.07

EIKN

Eikon Therapeutics, Inc. Common Stock

vs RZLT

Market Cap

$410.91M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SI

Shoulder Innovations, Inc.

vs RZLT

Market Cap

$406.16M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTA

Strata Critical Medical, Inc.

vs RZLT

Market Cap

$412.28M

PE Ratio

9.57

TTM Avg

9.86

3Y Avg

9.86

5Y Avg

9.86

CARL

Carlsmed, Inc.

vs RZLT

Market Cap

$405.74M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SENS

Senseonics Holdings, Inc.

vs RZLT

Market Cap

$414.18M

PE Ratio

N/A

TTM Avg

7.35

3Y Avg

7.35

5Y Avg

7.35

AVIR

Atea Pharmaceuticals, Inc.

vs RZLT

Market Cap

$404.14M

PE Ratio

N/A

TTM Avg

22.42

3Y Avg

51.74

5Y Avg

51.74

MPLT

MapLight Therapeutics, Inc.

vs RZLT

Market Cap

$420.28M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Rezolute, Inc. (RZLT)	$409.20M	N/A	N/A	N/A	N/A
Myriad Genetics, Inc. (MYGN)vs ›	$410.18M	N/A	178.15	100.22	67.93
Neurogene Inc. (NGNE)vs ›	$408.17M	N/A	21.17	21.07	21.07
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$410.91M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$406.16M	N/A	N/A	N/A	N/A
Strata Critical Medical, Inc. (SRTA)vs ›	$412.28M	9.57	9.86	9.86	9.86
Carlsmed, Inc. (CARL)vs ›	$405.74M	N/A	N/A	N/A	N/A
Senseonics Holdings, Inc. (SENS)vs ›	$414.18M	N/A	7.35	7.35	7.35
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$404.14M	N/A	22.42	51.74	51.74
MapLight Therapeutics, Inc. (MPLT)vs ›	$420.28M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$4.25

÷

Forward EPS (Est.)

$-0.70

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

RZLT PE Ratio Metrics

RZLT Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics